Monthly oncology tumor boards: a multidisciplinary approach to individualized patient care: gastric cancer.

October 27, 2020

Clinicians must consider disease stage, histology, biomarker expression and patient performance status to make decisions regarding optimal care. Treatment for localized disease requires surgical resection with neoadjuvant and/or adjuvant therapy as indicated, while advanced disease is typically treated with systemic therapy with or without radiation. Optimal treatment for resectable disease requires clinician awareness of current evidence regarding the recurrence and survival rates associated with various combined modality approaches. Decisions regarding treatment for advanced or metastatic gastric cancer require that clinicians be familiar with existing and new systemic therapies and targeted therapies as well as the most effective and tolerable combination regimens. Clinicians should regularly evaluate recent clinical trial data to make informed decisions on the most appropriate treatment plan, particularly as new targeted therapies become available.

Target audience

This educational program is designed to meet the educational needs of physicians/oncologists, nurse practitioners, nurses, physician assistants, pharmacists, and other health care professionals who manage patients with cancer.

Learning objectives

• Following this activity, participants should be able to:
• Recognize the importance of multidisciplinary care for patients with gastric cancer.
• Select the optimal treatment approach for patients with various presentations of gastric cancer.
• Review current evidence for treating advanced gastric cancer with targeted therapies to make informed treatment decisions.

https://education.nccn.org/node/88447#group-tabs-node-course-default4